With the increasing demand for contract manufacturing services from global clients, Wuxi Biologics has plans to expand its production capacity at its Worcester facility in Massachusetts, USA. With this move, the unit will add 12,000 liters of commercial drug substance capacity to its existing capacity of 24,000 liters.
Read on